维普中文期刊产品整合服务
18篇 您的检索式:作者名="Steinfeld SD"
    题名 作者 年代 出处 被引量
1Epratuzumab ( humanized anti CD22 antibody) in primary Sjogren 8 syndrome : an openlabel phase 1/II study 显示文摘Steinfeld SD Tant L Burmester GR 2006Arthritis Res Therapy2006,8,4:1
2Primary Sjogren' s syndrome:an open-label phase Ⅰ/Ⅱ study显示文摘Epratuzumab Steinfeld SD Tant L Burmester GR 0,,04:1
3Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjtgren's syndrome 显示文摘Steinfeld SD Appelboom T Delporte C 2002Arthritis Rheum2002,46,8:1
4Infliximab in patients with primary SjSgren's syndrome: a pilot study显示文摘Steinfeld SD Demols P Salmon I Appelboom T 2001Arthritis Rheum2001,44,:1
5Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjgren's syndrome显示文摘Steinfeld SD Appelboom T Delporte C 2002Arthritis Rheum2002,46,8:1
6Epratuzumab ( humanized anti-CD22 antibody) in autoimmune diseases 显示文摘Steinfeld SD Youinou P 2006Expert Opin Biol Ther2006,6,9:1
7Epratuzumab (humanised anti-CD22 antibody ) in primary Sjogren's syndrome: an open-label phase I / II study 显示文摘Steinfeld SD Tant L Burmester GR 2006Arthritis Res Ther2006,8,4:1
8Epratuzumab (humanised anti- CD22 antibody) in autoimmune diseases显示文摘STEINFELD SD YOUINOU P 2006Expert Opin Biol Ther2006,6,9:1
9Infliximab in patients with primary Sjogren's syndrome:a pilot study显示文摘Steinfeld SD Demols P Salmon I 2001Arthritis Rheum2001,44,:1
10Hu- manised anti-CD22 antibody in primary Sjogrens syndrome : an open-label-phase I/II study 显示文摘pratuzumab Steinfeld SD Tant L BurmesterGR 2006Arthritis Res Ther2006,8,4:1
11Epratuzumab(humanised anti-CD22 antibody) in primary Sj(o)gren'ssyndrome:An open-label phase Ⅰ/Ⅱ study显示文摘Steinfeld SD Tant L Burmester GR 2006Arthritis Res Ther2006,8,4:1
12(humanised anti-CD22 antibody) in primary Sjogren's syndrome:an open-label phase Ⅰ/Ⅱ study显示文摘 Tant L Burmester GR 2006Arthritis Res Ther2006,8,4:1
13Epratuzumab (a humanized anti-CD22 antibody) in primary sjogren's synclrome:an open-labed phase Ⅰ/Ⅱ study显示文摘Steinfeld SD Tant L Burmester GR 2006Arthritis Res Ther2006,20,84:1
14Infliximab in patients with primary Sjogren's syndrome: a pilot study 显示文摘Steinfeld SD Demols P Salmon I 2001Arthritis Rheum2001,44,10:1
15Infliximab in patients with primary Sj(o)gren's syndrome:A pilot study显示文摘Steinfeld SD Demols P Salmon I 2001Arthritis Rheum2001,44,10:1
16Epratuzumab (humanised anti-CD22 antibody) in primary Sj6gren's syndrome: an open-label phase I /II study显示文摘Steinfeld SD Tant L Burmester GR 2006Arthritis Res Ther2006,8,4:1
17Infliximab in patients with primary Sggrens syndrome:a pilot study显示文摘Steinfeld SD Demols P Salmon I 2001Arthritis Rheum2001,44,10:1
18Primary Sjogren's syndrome:an open-label phaseⅠ/Ⅱstudy显示文摘Epratuzumab Steinfeld SD Tant L Burmester GR 2006Arthritis Res Ther2006,8,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费